Marinus Pharmaceuticals Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Operating Revenue	5,314	4,918	4,247	5,030	4,364	4,161	Upgrade
Other Revenue	37.84	31.45	27.75	38.2	30.56	22.28	Upgrade
Revenue	5,352	4,950	4,274	5,068	4,395	4,183	Upgrade
Revenue Growth (YoY)	25.96%	15.80%	-15.66%	15.31%	5.07%	1.45%	Upgrade
Cost of Revenue	3,617	3,306	2,892	3,622	3,016	2,811	Upgrade
Gross Profit	1,735	1,644	1,382	1,446	1,379	1,371	Upgrade
Selling, General & Admin	944.91	905.01	885.24	1,080	940.73	873.52	Upgrade
Operating Expenses	944.38	904.71	885.24	1,083	941.78	873.52	Upgrade
Operating Income	790.36	739.13	497.01	363.37	437.35	497.93	Upgrade
Interest Expense	-7.31	-7.12	-8.55	-10.34	-10.47	-9.06	Upgrade
Interest & Investment Income	1.12	0.74	0.48	0.19	0.12	0.28	Upgrade
Earnings From Equity Investments	-	-	-	-	-	-0.75	Upgrade
Other Non Operating Income (Expenses)	-	-	-	-0.03	-	-	Upgrade
EBT Excluding Unusual Items	784.16	732.75	488.94	353.19	427	488.4	Upgrade
Impairment of Goodwill	-	-	-	-	-	-0.94	Upgrade
Gain (Loss) on Sale of Investments	1.33	-3.25	1.42	0.26	0.14	-10.9	Upgrade
Pretax Income	785.49	729.5	490.36	353.45	427.15	476.55	Upgrade
Income Tax Expense	150.78	130.49	98.2	78.02	82.56	77.76	Upgrade
Earnings From Continuing Operations	634.71	599.01	392.15	275.43	344.59	398.79	Upgrade
Minority Interest in Earnings	1.56	1.44	4.67	10.45	10.23	5.53	Upgrade
Net Income	636.27	600.45	396.82	285.88	354.82	404.32	Upgrade
Net Income to Common	636.27	600.45	396.82	285.88	354.82	404.32	Upgrade
Net Income Growth	49.20%	51.31%	38.81%	-19.43%	-12.24%	46.44%	Upgrade
Shares Outstanding (Basic)	558	558	558	558	558	586	Upgrade
Shares Outstanding (Diluted)	558	558	558	558	558	586	Upgrade
Shares Change (YoY)	-	-	-	-	-4.69%	-2.12%	Upgrade
EPS (Basic)	1.14	1.08	0.71	0.51	0.64	0.69	Upgrade
EPS (Diluted)	1.14	1.08	0.71	0.51	0.64	0.69	Upgrade
EPS Growth	49.20%	51.31%	38.81%	-19.43%	-7.92%	49.60%	Upgrade
Free Cash Flow	485.79	542.77	487.77	286.21	282.49	382.55	Upgrade
Free Cash Flow Per Share	0.87	0.97	0.87	0.51	0.51	0.65	Upgrade
Dividend Per Share	0.980	0.980	0.500	0.430	0.450	0.500	Upgrade
Dividend Growth	96.00%	96.00%	16.28%	-4.44%	-10.00%	-31.51%	Upgrade
Gross Margin	32.41%	33.21%	32.34%	28.54%	31.38%	32.79%	Upgrade
Operating Margin	14.77%	14.93%	11.63%	7.17%	9.95%	11.90%	Upgrade
Profit Margin	11.89%	12.13%	9.28%	5.64%	8.07%	9.67%	Upgrade
Free Cash Flow Margin	9.08%	10.97%	11.41%	5.65%	6.43%	9.15%	Upgrade
EBITDA	880.95	831	584.16	446.52	517.73	568.21	Upgrade
EBITDA Margin	16.46%	16.79%	13.67%	8.81%	11.78%	13.58%	Upgrade
D&A For EBITDA	90.59	91.87	87.14	83.15	80.38	70.28	Upgrade
EBIT	790.36	739.13	497.01	363.37	437.35	497.93	Upgrade
EBIT Margin	14.77%	14.93%	11.63%	7.17%	9.95%	11.90%	Upgrade
Effective Tax Rate	19.20%	17.89%	20.03%	22.07%	19.33%	16.32%	Upgrade
Revenue as Reported	5,354	4,952	4,276	5,068	4,395	4,184	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.